Portland Global Advisors LLC Abb Vie Inc. Transaction History

Portland Global Advisors LLC

$793 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $185,823 - $215,118	1,391 New	1,391 $207,000
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $33,838 - $38,970	-234 Reduced 12.75%	1,601 $255,000
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $19,640 - $23,553	-142 Reduced 7.18%	1,835 $297,000
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $14,494 - $16,624	-108 Reduced 5.18%	1,977 $265,000
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $8,532 - $10,847	-62 Reduced 2.89%	2,085 $319,000
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $21,512 - $26,691	-163 Reduced 7.06%	2,147 $348,000
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $7,627 - $9,651	-71 Reduced 2.98%	2,310 $313,000
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $31,562 - $35,163	-300 Reduced 11.19%	2,381 $268,000
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $106,810 - $144,205	-1,327 Reduced 33.11%	2,681 $287,000
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $1,288 - $1,512	-15 Reduced 0.37%	4,008 $351,000
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $295,167 - $394,978	4,023 New	4,023 $395,000
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $176,910 - $212,697	-2,809 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $14,191 - $18,139	216 Added 8.33%	2,809 $204,000
Q4 2018 Jan 23, 2019	SELL	$77.85 - $96.01 $3,892 - $4,800	-50 Reduced 1.89%	2,593 $239,000
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $14,454 - $17,103	161 Added 6.49%	2,643 $245,000
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $9,403 - $10,312	-105 Reduced 4.06%	2,482 $240,000
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $180,701 - $230,812	2,587	2,587 $230,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portland Global Advisors LLC with notifications on news.

Account